763 related articles for article (PubMed ID: 22959595)
1. Exosomes for drug delivery - a novel application for the mesenchymal stem cell.
Lai RC; Yeo RW; Tan KH; Lim SK
Biotechnol Adv; 2013; 31(5):543-51. PubMed ID: 22959595
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery.
Yeo RW; Lai RC; Zhang B; Tan SS; Yin Y; Teh BJ; Lim SK
Adv Drug Deliv Rev; 2013 Mar; 65(3):336-41. PubMed ID: 22780955
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
Millard SM; Fisk NM
Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of mesenchymal stem cell-derived microvesicles.
Biancone L; Bruno S; Deregibus MC; Tetta C; Camussi G
Nephrol Dial Transplant; 2012 Aug; 27(8):3037-42. PubMed ID: 22851627
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.
Katsuda T; Kosaka N; Takeshita F; Ochiya T
Proteomics; 2013 May; 13(10-11):1637-53. PubMed ID: 23335344
[TBL] [Abstract][Full Text] [Related]
6. Exosomes as a potential tool for a specific delivery of functional molecules.
Nazarenko I; Rupp AK; Altevogt P
Methods Mol Biol; 2013; 1049():495-511. PubMed ID: 23913240
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.
Lai RC; Yeo RW; Tan KH; Lim SK
Regen Med; 2013 Mar; 8(2):197-209. PubMed ID: 23477399
[TBL] [Abstract][Full Text] [Related]
8. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration.
Shimbo K; Miyaki S; Ishitobi H; Kato Y; Kubo T; Shimose S; Ochi M
Biochem Biophys Res Commun; 2014 Mar; 445(2):381-7. PubMed ID: 24525123
[TBL] [Abstract][Full Text] [Related]
9. Delivery of Small Interfering RNAs to Cells via Exosomes.
Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell exosomes.
Lai RC; Yeo RW; Lim SK
Semin Cell Dev Biol; 2015 Apr; 40():82-8. PubMed ID: 25765629
[TBL] [Abstract][Full Text] [Related]
12. Isolation and Characterization of Exosome from Human Embryonic Stem Cell-Derived C-Myc-Immortalized Mesenchymal Stem Cells.
Lai RC; Yeo RW; Padmanabhan J; Choo A; de Kleijn DP; Lim SK
Methods Mol Biol; 2016; 1416():477-94. PubMed ID: 27236691
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of exosomes: current perspectives.
Simpson RJ; Jensen SS; Lim JW
Proteomics; 2008 Oct; 8(19):4083-99. PubMed ID: 18780348
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.
Figueroa FE; Cuenca Moreno J; La Cava A
Expert Opin Drug Discov; 2014 May; 9(5):555-66. PubMed ID: 24655067
[TBL] [Abstract][Full Text] [Related]
15. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
[TBL] [Abstract][Full Text] [Related]
16. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
Yamashita T; Takahashi Y; Takakura Y
Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
Xitong D; Xiaorong Z
Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
[TBL] [Abstract][Full Text] [Related]
18. Functions and application of exosomes.
Qin J; Xu Q
Acta Pol Pharm; 2014; 71(4):537-43. PubMed ID: 25272880
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
20. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy.
Kourembanas S
Annu Rev Physiol; 2015; 77():13-27. PubMed ID: 25293529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
